Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
99 100 Next >
Scholar Rock In Spotlight After FDA Refuses To Approve Muscular Atrophy Treatment Over Third-Party Manufacturing Facility Issues
Via Stocktwits
Tickers EAOR SRRK VFMO
Exposures Product Safety
Scholar Rock, A Top 10% Stock, Dives After Catalent Issues Hamper SMA Drug
Via Investor's Business Daily
Tickers NVO SRRK
Exposures Product Safety
Amneal Pharma Stock Rises On FDA Approval For Generic Version Of AbbVie’s Eyedrops
Via Stocktwits
Tickers AGN AMRX
Exposures Product Safety
Nyoteni Launches Revolutionary Exosome-Powered Night Cream with Unmatched Potency
Via Press Release Distribution Service
Exposures COVID-19 Product Safety
What's Pfizer Getting in Its $7.3 Billion Metsera Buyout?
Via The Motley Fool
Tickers GS LLY MTSR PFE
Exposures Product Safety
Johnson & Johnson Stock Weathers Trump’s Tylenol Attacks Better Than Kenvue Amid Dipping Retail Confidence — What’s Holding Losses in Check?
Via Stocktwits
Topics Government
Tickers JNJ KVUE
Exposures Political Product Safety
2 Mid-Cap Stocks with Promising Prospects and 1 Facing Challenges
Via StockStory
Topics Economy
Tickers CPAY DXCM MTZ
Exposures Product Safety Supply Chain
Scott Sterling Redefines California Living Through Artful Design and Real Estate Expertise
Via Get News
Topics Product Recall
Exposures Legal Product Safety
U.S. Government Shutdown Looms: A Guide for Investors Navigating Political and Economic Uncertainty
Via MarketMinute
Topics Bonds Economy
Tickers DUK JNJ KO LDOS LMT NEE
Exposures Debt Markets Economy Product Safety
Top 5 Stocks to Watch in Q4 2025: Navigating a Shifting Economic Landscape
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Tickers AAPL AMD AMZN HD INTC JPM
Exposures Artificial Intelligence Economy Financial
Big Pharma's Epicenter Shift: Eli Lilly and the Reshaping of the Weight-Loss Drug Market
Via MarketMinute
Topics Economy Intellectual Property
Tickers AMGN AZN LLY NVO PFE RHHBY
Exposures Intellectual Property Product Safety Supply Chain
FDA Clears Merck's One-Minute Cancer Shot
Via Benzinga
Tickers MRK
Exposures Product Safety
BADCO Transforms from Industry Secret to National Brand with Humor, Heart, and Howie Mandel
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
FDA Delays Key Sanofi Multiple Sclerosis Drug Decision
Via Benzinga
Tickers REGN SNY
Exposures Product Safety
Actuate Therapeutics Stock Rises After Updating FDA Application For Lead Investigational Drug In Treating Pancreatic Cancer
Via Stocktwits
Tickers ACTU IWMW TSLA VTWG
Exposures Product Safety
Johnson & Johnson's Uninterrupted Dividend Growth: Innovation in Medicine and MedTech Drives Strong Q2 2025 Performance
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
Tickers ABBV AMGN BMY BSX ISRG JNJ
Exposures Artificial Intelligence Intellectual Property Product Safety
Eli Lilly's Ascent: A New Era in Obesity Treatment Driven by Zepbound and Orforglipron
Via MarketMinute
Topics Economy
Tickers AMGN LLY NVO
Exposures Product Safety Supply Chain
IBD 50's Tempus AI Hits Record High On Yet Another FDA Clearance
Via Investor's Business Daily
Topics Artificial Intelligence Intellectual Property
Tickers PFE TEM
Exposures Artificial Intelligence Intellectual Property Product Safety
Shareholders That Lost Money on Cytokinetics, Incorporated (CYTK) Should Contact Levi & Korsinsky About Pending Class Action - CYTK
Via NewMediaWire
Topics Earnings Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
Levi & Korsinsky Notifies Shareholders of Savara Inc. (SVRA) of a Class Action Lawsuit and an Upcoming Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
Levi & Korsinsky Notifies Shareholders of Replimune Group, Inc. (REPL) of a Class Action Lawsuit and an Upcoming Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Notifies Shareholders of Savara Inc. (SVRA) of a Class Action Lawsuit and an Upcoming Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers SVRA
Exposures Financial Legal Product Safety
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for Investors Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Shareholders That Lost Money on Cytokinetics, Incorporated (CYTK) Should Contact Levi &amp; Korsinsky About Pending Class Action - CYTK
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
Tickers CYTK
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Notifies Shareholders of Replimune Group, Inc. (REPL) of a Class Action Lawsuit and an Upcoming Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for Investors Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
No More Spreadsheets Two Childhood Friends Launch Card Codex – A Pokmon Card Database Built for Collectors
Via Binary News Network
Topics Product Recall
Exposures Legal Product Safety
Travel Dine Stay Announces Global Nomad Journey to 92 Countries
Via Press Release Distribution Service
Topics Product Recall Retirement
Exposures Legal Pension Product Safety
Select Motorz Offers Expert Tips for Thorough Used Car Inspections
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Johnson & Johnson Confronts the End of its Talc Legacy with Multi-Billion Dollar Settlements
Via MarketMinute
Topics Bankruptcy Death Lawsuit
Tickers JNJ KVUE
Exposures Death Financial Legal
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.